Sylvia Cheung
Finanzdirektor/CFO bei OCULIS HOLDING AG
Vermögen: 785 662 $ am 31.05.2024
Aktive Positionen von Sylvia Cheung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCULIS HOLDING AG | Finanzdirektor/CFO | 01.09.2020 | - |
| Public Communications Contact | 01.09.2020 | - |
Karriereverlauf von Sylvia Cheung
Ehemalige bekannte Positionen von Sylvia Cheung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.10.2005 | 10.08.2020 |
| Finanzdirektor/CFO | 01.04.2013 | 10.08.2020 | |
| Investor Relations Kontakt | 01.10.2005 | 10.08.2020 | |
| Unternehmenssekretär | 01.04.2013 | 04.03.2020 | |
| Treasurer | 01.04.2013 | 10.08.2020 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 01.01.2000 | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01.01.1995 | 01.01.2000 |
Ausbildung von Sylvia Cheung
| University of Massachusetts | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
| Israel | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| OCULIS HOLDING AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Börse
- Insiders
- Sylvia Cheung
- Erfahrung
